ELAN

$24.571.95%0.47

Nachbörslich: 24.570.00 0.00%

Elanco Animal Health Inc (ELAN)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$24.10

Offen:

$24.23

24-Stunden-Volumen:

6,460,436

Relatives Volumen:

1.32

Marktkapitalisierung:

$12.28B

Einnahmen:

$4.89B

Nettoeinkommen (Verlust:

-$242.00M

KGV:

EPS:

-$0.489

Netto-Cashflow:

$315.00M

1W Leistung:

+8.48%

1M Leistung:

+10.98%

6M Leistung:

+9.15%

1Y Leistung:

+7.53%

1-Tages-Spanne:

$24.07$24.82

1-Wochen-Bereich:

$22.56$24.82

52-Wochen-Spanne:

$19.40$27.98

Elanco Animal Health Inc Aktie (ELAN) Unternehmensprofil

Firmenname

Elanco Animal Health Inc

Sektor

Healthcare

Branche

Drug Manufacturers - Specialty & Generic

Telefon

877-352-6261

Adresse

450 ELANCO CIRCLE, INDIANAPOLIS, USA

Mitarbeiter

9,900

@Elanco

Nächster Verdiensttermin

2026-11-06

Neueste SEC-Einreichungen

SEC

ELAN-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Elanco Animal Health Inc Aktie (ELAN) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-10-20	Herabstufung	Jefferies	Buy → Hold
2026-10-16	Eingeleitet	Goldman	Buy
2026-04-15	Eingeleitet	Citigroup	Buy
2026-01-22	Hochstufung	Piper Sandler	Neutral → Overweight
2025-12-09	Eingeleitet	Barclays	Overweight
2025-11-21	Eingeleitet	KeyBanc Capital Markets	Overweight
2025-11-19	Hochstufung	Argus	Hold → Buy
2025-10-07	Hochstufung	JP Morgan	Neutral → Overweight
2025-07-17	Hochstufung	Leerink Partners	Market Perform → Outperform
2025-06-26	Hochstufung	William Blair	Mkt Perform → Outperform
2024-12-09	Eingeleitet	UBS	Buy
2024-12-02	Eingeleitet	Leerink Partners	Market Perform
2024-09-19	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-01-05	Hochstufung	Stifel	Hold → Buy
2023-12-19	Eingeleitet	Jefferies	Buy
2023-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-12-07	Eingeleitet	Exane BNP Paribas	Outperform
2023-04-20	Hochstufung	Barclays	Equal Weight → Overweight
2022-08-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-08-16	Herabstufung	JP Morgan	Overweight → Neutral
2022-07-21	Herabstufung	Goldman	Buy → Sell
2022-07-12	Eingeleitet	Piper Sandler	Neutral
2021-11-18	Eingeleitet	Morgan Stanley	Overweight
2021-10-28	Herabstufung	Stifel	Buy → Hold
2021-08-05	Resumed	Credit Suisse	Outperform
2021-06-15	Hochstufung	Cleveland Research	Underperform → Neutral
2021-05-11	Hochstufung	Barclays	Underweight → Equal Weight
2021-05-11	Hochstufung	Gabelli & Co	Hold → Buy
2021-04-15	Eingeleitet	Stifel	Buy
2021-03-22	Herabstufung	Gabelli & Co	Buy → Hold
2021-02-26	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-09	Herabstufung	Argus	Buy → Hold
2020-11-09	Herabstufung	Barclays	Overweight → Underweight
2020-08-20	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-08-13	Resumed	Credit Suisse	Neutral
2020-08-04	Resumed	Goldman	Buy
2020-07-27	Herabstufung	Cleveland Research	Neutral → Underperform
2020-04-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-10	Eingeleitet	Raymond James	Mkt Perform
2019-12-19	Hochstufung	BofA/Merrill	Neutral → Buy
2019-11-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2019-09-23	Eingeleitet	Barclays	Overweight
2019-08-26	Herabstufung	BofA/Merrill	Buy → Neutral
2019-08-15	Hochstufung	UBS	Sell → Neutral
2019-05-23	Eingeleitet	Guggenheim	Neutral
2019-03-18	Hochstufung	BofA/Merrill	Neutral → Buy
2019-03-13	Resumed	Morgan Stanley	Equal-Weight
2019-02-12	Eingeleitet	William Blair	Mkt Perform
2019-01-23	Eingeleitet	UBS	Sell
2019-01-15	Eingeleitet	Argus	Buy
2018-10-15	Eingeleitet	Morgan Stanley	Equal-Weight

Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	4,715.00	4,439.00	4,417.00	4,411.00	4,765.00
Cost of revenue USD (M)	2,122.00	2,003.00	1,931.00	1,913.00	2,134.00
Gross profit USD (M)	2,593.00	-	2,486.00	2,498.00	2,631.00
Research and development USD (M)	368.00	344.00	327.00	321.00	369.00
Operating expenses USD (M)	-	3,951.00	3,681.00	2,570.00	3,198.00
Operating income USD (M)	-	-	-1,195.00	-72.00	-567.00
Income before tax USD (M)	-224.00	488.00	-1,195.00	-72.00	-567.00
Income tax expense USD (M)	8.00	150.00	36.00	6.00	-95.00
Net income USD (M)	-232.00	338.00	-1,231.00	-78.00	-472.00
Basic EPS USD/shares	-0.47	0.68	-2.50	-0.16	-0.97
Diluted EPS USD/shares	-0.47	0.68	-2.50	-0.16	-0.97
Basic weighted shares shares (M)	496.40	494.00	492.30	488.30	487.20
Diluted weighted shares shares (M)	496.40	497.30	492.30	488.30	487.20
Selling, general and administrative USD (M)	1,430.00	1,314.00	1,285.00	1,265.00	1,404.00

Elanco Animal Health Inc-Aktie (ELAN) Insiderhandel

Bettington Timothy JOct 15 '26
SEE REMARKS
Transaktion
Sale
Kosten
$23.00
#Aktien
4,350
Wert ($)
100,050
#Aktien Gesamt
138,911
Bettington Timothy JOct 15 '26
Officer
Transaktion
Proposed Sale
Kosten
$23.00
#Aktien
4,350
Wert ($)
100,050
#Aktien Gesamt
0
Kurzius Lawrence ErikAug 20 '26
Director
Transaktion
Buy
Kosten
$23.40
#Aktien
40,000
Wert ($)
935,920
#Aktien Gesamt
188,647
O'Neill ShivAug 18 '26
GC AND CORP SEC
Transaktion
Buy
Kosten
$23.58
#Aktien
3,998
Wert ($)
94,273
#Aktien Gesamt
87,832
Harrington Michael JAug 12 '26
Director
Transaktion
Buy
Kosten
$21.82
#Aktien
5,000
Wert ($)
109,100
#Aktien Gesamt
131,451
VanHimbergen Robert MAug 07 '26
EVP and CFO
Transaktion
Buy
Kosten
$23.08
#Aktien
4,200
Wert ($)
96,926
#Aktien Gesamt
137,516
Herendeen PaulAug 07 '26
Director
Transaktion
Buy
Kosten
$23.68
#Aktien
10,000
Wert ($)
236,850
#Aktien Gesamt
111,687
Modi Rajeev A.May 15 '26
SEE REMARKS
Transaktion
Buy
Kosten
$20.35
#Aktien
4,911
Wert ($)
99,939
#Aktien Gesamt
160,812
Simmons Jeffrey NMay 15 '26
PRESIDENT, CEO AND DIRECTOR
Transaktion
Buy
Kosten
$20.09
#Aktien
4,971
Wert ($)
99,843
#Aktien Gesamt
171,971
Kurzius Lawrence ErikDec 12 '25
Director
Transaktion
Buy
Kosten
$21.30
#Aktien
10,000
Wert ($)
213,000
#Aktien Gesamt
131,773

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Bettington Timothy J	SEE REMARKS	Oct 15 '26	Sale	$23.00	4,350	100,050	138,911
Bettington Timothy J	Officer	Oct 15 '26	Proposed Sale	$23.00	4,350	100,050	0
Kurzius Lawrence Erik	Director	Aug 20 '26	Buy	$23.40	40,000	935,920	188,647
O'Neill Shiv	GC AND CORP SEC	Aug 18 '26	Buy	$23.58	3,998	94,273	87,832
Harrington Michael J	Director	Aug 12 '26	Buy	$21.82	5,000	109,100	131,451
VanHimbergen Robert M	EVP and CFO	Aug 07 '26	Buy	$23.08	4,200	96,926	137,516
Herendeen Paul	Director	Aug 07 '26	Buy	$23.68	10,000	236,850	111,687
Modi Rajeev A.	SEE REMARKS	May 15 '26	Buy	$20.35	4,911	99,939	160,812
Simmons Jeffrey N	PRESIDENT, CEO AND DIRECTOR	May 15 '26	Buy	$20.09	4,971	99,843	171,971
Kurzius Lawrence Erik	Director	Dec 12 '25	Buy	$21.30	10,000	213,000	131,773

Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten

Nov 02, 2026

RadNet (RDNT) Reports Next Week: Wall Street Expects Earnings Growth - Zacks Investment Research

Nov 02, 2026

Oct 30, 2026

4 Medical Stocks With a Healthy Shot at Q3 Earnings Beats - Zacks Investment Research

Oct 30, 2026

Oct 22, 2026

Elanco Animal Health Incorporated Announces Management Changes - www.marketscreener.com

Oct 22, 2026

Oct 21, 2026

Form 4 Elanco Animal Health: Rajeev A. Modi (Officer) For: 16 October By Investing.com - Investing.com South Africa

Oct 21, 2026

Oct 20, 2026

Elanco Animal Health Slides as Analyst Downgrade Pressures Shares - Quiver Quantitative

Oct 20, 2026

Elanco CFO Robert VanHimbergen Purchases 8.366 Deferred Stock Units at $23.55 Each - Kalkine Media

Oct 20, 2026

An executive receives 62.7147 stock units in an Elanco (ELAN) award priced at $23.55 per unit. - Stock Titan

Oct 20, 2026

Elanco (ELAN) CEO Jeffrey N. Simmons acquires stock units priced at $23.55 each. - Stock Titan

Oct 20, 2026

An award of 8.366 stock units at $23.55 goes to Elanco (ELAN) CFO Robert M. VanHimbergen. - Stock Titan

Oct 20, 2026

Why is Elanco Animal Health stock down 5% today? By Investing.com - Investing.com Canada

Oct 20, 2026

Jefferies downgrades Elanco Animal Health stock rating on pricing risks By Investing.com - Investing.com Canada

Oct 20, 2026

Oct 19, 2026

Timothy J. Bettington Disposes 4,350 Shares of Elanco Animal Health Stock at $23 Each on October 15, 2026 - Kalkine Media

Oct 19, 2026

Mosaic Co. stock underperforms Monday when compared to competitors - MarketWatch

Oct 19, 2026

At $23 each, Elanco (ELAN) officer Bettington sells 4,350 shares under a trading plan. - Stock Titan

Oct 19, 2026

Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research

Oct 19, 2026

Telescope Innovations joins Canadian delegation at BIOPLUS-INTERPHEX Korea to boost AI-driven pharma R&D. - Pluang

Oct 19, 2026

Kane Biotech unveils new brand and website to h... - Pluang

Oct 19, 2026

Oct 15, 2026

Officer Timothy J. Bettington proposes selling 4,350 shares of Elanco Animal Health (ELAN). - Stock Titan

Oct 15, 2026

Oct 14, 2026

Dwight Evans Stock Trades and Disclosures - TechGraph

Oct 14, 2026

Oct 06, 2026

An executive at Elanco (ELAN) acquires 66.7087 stock-linked units at $22.14 each. - Stock Titan

Oct 06, 2026

At $22.14 each, Elanco (ELAN) CFO acquires 8.8988 units payable in shares or cash. - Stock Titan

Oct 06, 2026

A 127.6843-unit stock grant brings Elanco (ELAN) CEO's holdings to 25,499.2826 stock-linked units. - Stock Titan

Oct 06, 2026

Oct 01, 2026

Deferring cash fees, Elanco (ELAN) director Kapila K. Anand acquires 642 stock-linked units. - stocktitan.net

Oct 01, 2026

Sep 22, 2026

Elanco Animal Health CEO Jeffrey N. Simmons Reports Acquisition of Deferred Stock Units - Kalkine Media

Sep 22, 2026

Form 4 Elanco Animal Health For: 22 September By Investing.com - Investing.com Nigeria

Sep 22, 2026

Form 4 Elanco Animal Health For: 22 September By Investing.com - Investing.com Canada

Sep 22, 2026

Elanco Animal Health Incorporated (ELAN) Latest Press Releases & Corporate News - finance.yahoo.com

Sep 11, 2026

Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement - Yahoo Finance

Sep 11, 2026

Sep 10, 2026

Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - PR Newswire

Sep 10, 2026

Sep 09, 2026

Elanco Animal Health (ELAN) CFO receives 8 deferred stock units - Stock Titan

Sep 09, 2026

Deferred stock award lifts Elanco Animal Health (NYSE: ELAN) exec's holdings - Stock Titan

Sep 09, 2026

Elanco (NYSE: ELAN) CEO adds to deferred pay with new stock grant - Stock Titan

Sep 09, 2026

Elanco Animal Health (ELAN) 10K Form and Latest SEC Filings 2026 - MarketBeat

Sep 09, 2026

Sep 08, 2026

Mutts With a Mission: How Elanco and Medical Mutts Transform Lives Together - CSRwire

Sep 08, 2026

Sep 04, 2026

Elanco Animal Health Stock Price Forecast. Should You Buy ELAN? - StockInvest.us

Sep 04, 2026

Elanco Director Purchases 40,000 Shares for $936,000 - Yahoo Finance

Sep 04, 2026

Elanco Director Purchases 40,000 Shares for $936,000 - The Motley Fool

Sep 04, 2026